Lista de obras -

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

artículo científico publicado en 2015

A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer

artículo científico publicado en 2017

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

artículo científico publicado en 2019

A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers

artículo científico publicado en 2017

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

artículo científico publicado en 2016

An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer

artículo científico publicado en 2019

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer

scientific article published on 27 February 2019

Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer ⬇️

artículo científico publicado el 30 de noviembre de 2010

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.

artículo científico publicado en 2018

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2019

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

artículo científico publicado en 2016

Breast cancer genomics and immuno-oncological markers to guide immune therapies.

artículo científico publicado en 2017

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes ⬇️

artículo científico publicado el 24 de diciembre de 2011

Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression

artículo científico publicado en 2019

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

scientific article published on 20 August 2019

Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes

artículo científico publicado en 2019

Co-regulated gene expression of splicing factors as drivers of cancer progression

article

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

scientific article published on 07 January 2014

Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

artículo científico publicado en 2018

Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers

artículo científico publicado en 2017

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells

artículo científico publicado en 2015

Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression

artículo científico publicado en 2018

Functional Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

article

Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons.

artículo científico publicado en 2018

High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.

artículo científico publicado en 2017

Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer

artículo científico publicado en 2014

Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.

artículo científico publicado en 2015

Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer

artículo científico publicado en 2018

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2016

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

artículo científico publicado en 2009

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

artículo científico publicado en 2013

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

artículo científico publicado en 2018

MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.

artículo científico publicado en 2014

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

artículo científico publicado en 2010

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

artículo científico publicado en 2019

Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers

artículo científico publicado en 2018

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation

article

Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.

artículo científico publicado en 2010

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer

artículo científico publicado en 2017

Predicting paclitaxel-induced neutropenia using the DMET platform

artículo científico publicado en 2015

Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.

artículo científico publicado en 2016

Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer ⬇️

artículo científico publicado el 21 de mayo de 2011

Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation

artículo científico publicado en 2017

Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

artículo científico

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

artículo científico publicado en 2021

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.

artículo científico publicado en 2018

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome.

artículo científico publicado en 2018

The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.

artículo científico publicado en 2016

The circular RNome of primary breast cancer

scientific article published on 28 January 2019

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

scientific article published on 30 September 2019

Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes

scientific article published on 05 July 2019

Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features

artículo científico publicado en 2021

Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations

artículo científico publicado en 2018

mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients ⬇️

artículo científico publicado el 19 de abril de 2011

Lista de obras de

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer

Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer ⬇️

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

Breast cancer genomics and immuno-oncological markers to guide immune therapies.

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes ⬇️

Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes

Co-regulated gene expression of splicing factors as drivers of cancer progression

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells

Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression

Functional Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons.

High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.

Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer

Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.

Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation

Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer

Predicting paclitaxel-induced neutropenia using the DMET platform

Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.

Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer ⬇️

Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation

Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome.

The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.

The circular RNome of primary breast cancer

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes

Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features

Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations

mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients ⬇️